State‐of‐the‐art treatment of systemic lupus erythematosus
Y Tanaka - International journal of rheumatic diseases, 2020 - Wiley Online Library
As glucocorticoids and immunosuppressive drugs are non‐specific therapeutic agents that
cause many adverse reactions, the development of biologicals aiming to control specific …
cause many adverse reactions, the development of biologicals aiming to control specific …
[HTML][HTML] State‐of‐the‐art treatment of systemic lupus erythematosus
Y Tanaka - International Journal of Rheumatic Diseases, 2020 - ncbi.nlm.nih.gov
As glucocorticoids and immunosuppressive drugs are non‐specific therapeutic agents that
cause many adverse reactions, the development of biologicals aiming to control specific …
cause many adverse reactions, the development of biologicals aiming to control specific …
State‐of‐the‐art treatment of systemic lupus erythematosus
Y Tanaka - International Journal of Rheumatic Diseases, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> As glucocorticoids and immunosuppressive
drugs are non‐specific therapeutic agents that cause many adverse reactions, the …
drugs are non‐specific therapeutic agents that cause many adverse reactions, the …
State-of-the-art treatment of systemic lupus erythematosus.
Y Tanaka - International Journal of Rheumatic Diseases, 2020 - europepmc.org
As glucocorticoids and immunosuppressive drugs are non‐specific therapeutic agents that
cause many adverse reactions, the development of biologicals aiming to control specific …
cause many adverse reactions, the development of biologicals aiming to control specific …
State‐of‐the‐art treatment of systemic lupus erythematosus.
Y Tanaka - International Journal of Rheumatic Diseases, 2020 - search.ebscohost.com
As glucocorticoids and immunosuppressive drugs are non‐specific therapeutic agents that
cause many adverse reactions, the development of biologicals aiming to control specific …
cause many adverse reactions, the development of biologicals aiming to control specific …
State-of-the-art treatment of systemic lupus erythematosus
Y Tanaka - International journal of rheumatic diseases, 2020 - pubmed.ncbi.nlm.nih.gov
As glucocorticoids and immunosuppressive drugs are non-specific therapeutic agents that
cause many adverse reactions, the development of biologicals aiming to control specific …
cause many adverse reactions, the development of biologicals aiming to control specific …